Hologic
In Brief This Week: Hologic, Illumina, LGC Biosearch, Agilent, Abbott, Eurofins, Centogene, More
News items for the week of Sept. 16, 2024.
New Data Shore Up Evidence for Paired Tumor Origin, Molecular Testing in Cancer of Unknown Primary
Premium
Biotheranostics' CancerType ID can predict tumor origins for the majority of CUP patients, with reflex biomarker testing finding those eligible for targeted treatment.
Hologic Organic Q3 Revenues Rise 6 Percent on Growth in Non-COVID Molecular Testing
The firm's non-COVID organic molecular diagnostics revenues jumped 11 percent on a constant currency basis while cytology and perinatal fell 4 percent.
JP Morgan Initiates Coverage of Hologic With Neutral Rating
The investment bank said in a note to investors that Hologic's strong credit statistics and ratings are priced in, and investors are waiting for a return to growth and margin improvements.
In Brief This Week: TriLink Biotech, Centogene, PreventionGenetics, InformedDNA, Karius, More
News items for the week of May 13, 2024.